Fernanda Guioti Puga1, Renata Helena Candido Pocente2, Erica Chimara3, Valdes Roberto Bollela1. 1. Ribeirão Preto School of Medicine, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil. 2. Mycobacteria Laboratory of Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto, Brazil. 3. Adolfo Lutz Institute, Central Mycobacteria Laboratory, São Paulo, Brazil.
Abstract
BACKGROUND: Nontuberculous mycobacteria (NTM) have been identified with increasing frequency in the clinical practice. The aim of this study was to characterize NTM isolates in respiratory specimens from patients with pulmonary disease and to correlate this with clinical/radiological findings, decision to start treatment and outcomes. METHODS: A cross-sectional descriptive study was performed and included all patients who had at least one NTM isolated in respiratory specimens between 2011 and 2014. NTM culture was performed in liquid medium followed by immunochromatographic identification (anti-MPT64). Species identification was based on nucleic acid amplification followed by restriction analysis of a 441 bp fragment of the hsp65 gene (hsp65 PRA) and patients' records were reviewed. RESULTS: From 14,394 cultures in 4 years, 590 (4.10%) grew NTM and 305 (51.7%) isolates were characterized till species level, representing 290 patients including those with and without human immunodeficiency virus (HIV) infection. Two hundred and eleven non-HIV patients had NTM isolated from respiratory specimens, 49 (23.2%) had criteria for active disease based on the American Thoracic Society (ATS) 2007. The majority was men above 51 years old and M. intracellulare was detected in 59.2% (29/49), followed by M. avium 14.3% (7/49), and M. abscessus 12.2% (6/49). CONCLUSIONS: Old age, nodular and nodular/bronchiectasis radiographic pattern, previous tuberculosis (TB) treatment and M. intracellulare were more frequent among NTM-disease patients compared to those only colonized. Positive culture and maintenance of clinical symptoms (poor outcome) was a rule when M. abscessus caused NTM-disease. Positive acid-fast smear in respiratory specimen is a strong predictor of disease.
BACKGROUND: Nontuberculous mycobacteria (NTM) have been identified with increasing frequency in the clinical practice. The aim of this study was to characterize NTM isolates in respiratory specimens from patients with pulmonary disease and to correlate this with clinical/radiological findings, decision to start treatment and outcomes. METHODS: A cross-sectional descriptive study was performed and included all patients who had at least one NTM isolated in respiratory specimens between 2011 and 2014. NTM culture was performed in liquid medium followed by immunochromatographic identification (anti-MPT64). Species identification was based on nucleic acid amplification followed by restriction analysis of a 441 bp fragment of the hsp65 gene (hsp65 PRA) and patients' records were reviewed. RESULTS: From 14,394 cultures in 4 years, 590 (4.10%) grew NTM and 305 (51.7%) isolates were characterized till species level, representing 290 patients including those with and without human immunodeficiency virus (HIV) infection. Two hundred and eleven non-HIV patients had NTM isolated from respiratory specimens, 49 (23.2%) had criteria for active disease based on the American Thoracic Society (ATS) 2007. The majority was men above 51 years old and M. intracellulare was detected in 59.2% (29/49), followed by M. avium 14.3% (7/49), and M. abscessus 12.2% (6/49). CONCLUSIONS: Old age, nodular and nodular/bronchiectasis radiographic pattern, previous tuberculosis (TB) treatment and M. intracellulare were more frequent among NTM-disease patients compared to those only colonized. Positive culture and maintenance of clinical symptoms (poor outcome) was a rule when M. abscessus caused NTM-disease. Positive acid-fast smear in respiratory specimen is a strong predictor of disease.
Entities:
Keywords:
M. abscessus; M. avium-intracellulare infection; Nontuberculous mycobacteria (NTM); diagnostic imaging; pulmonary diseases
Authors: David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop Journal: Am J Respir Crit Care Med Date: 2007-02-15 Impact factor: 21.405
Authors: Ana Roberta Fusco da Costa; Joseph O Falkinham; Maria Luiza Lopes; Adriana Rodrigues Barretto; João Soares Felicio; Lúcia Helena Messias Sales; Jeann Ricardo da Costa Bahia; Emilyn Costa Conceição; Karla Valéria Batista Lima Journal: PLoS Negl Trop Dis Date: 2013-07-18
Authors: Theodore K Marras; David Mendelson; Alex Marchand-Austin; Kevin May; Frances B Jamieson Journal: Emerg Infect Dis Date: 2013-11 Impact factor: 6.883
Authors: Aline Dos Santos Peixoto; Lílian Maria Lapa Montenegro; Andrea Santos Lima; Fábio Lopes Melo; Walter Lins Barbosa Júnior; Maria Madileuza Carneiro Neves; Jesus Pais Ramos; Haiana Charifker Schindler; Zulma Maria Medeiros Journal: Rev Soc Bras Med Trop Date: 2020-11-06 Impact factor: 1.581
Authors: Ana Carolina de Oliveira de Lima; Karen Barros Schmid; Hilda Ferreira de Melo; Rafaella Christine Athayde; Rossiclea Lins Monte; Isabela Neves de Almeida; Silvana Spíndola de Miranda; Afrânio Kritski; Maria Lucia Rossetti; Marcelo Cordeiros-Santos Journal: Rev Soc Bras Med Trop Date: 2022-08-05 Impact factor: 2.141